Handbook of Viral Bioterrorism and Biodefense

Handbook of Viral Bioterrorism and Biodefense

by Erik De Clercq, Earl R. Kern

150 pages· 2003· ISBN 9780444513267
About
The atrocities of 11 September 2001 and the more recent casualties due to anthrax bioterrorism have dramatically emphasized the potential danger of biological warfare and bioterrorism. The editors of "Antiviral Research" have taken the initiative to edit a special issue of the Journal, focusing on Viral Bioterrorism and Biodefense. It is the first time in history that a special volume has been dedicated to this topic, which in view of the current circumstances is timely, appropriate and relevant. To what extent could viruses be "weaponized", i.e. turned into biological weapons, and used for biowarfare, which viruses would lend themselves for this purpose, how should we estimate the risk and the consequences, which diagnostic measures should be taken, and how should we react prophylactically, and, if needed, therapeutically?

Discuss Handbook of Viral Bioterrorism and Biodefense with other readers

Join or start a book club for Handbook of Viral Bioterrorism and Biodefense on Readfeed. Live chat, shared reading progress, and AI discussion questions — free to get started.

Frequently asked questions

How do I join a book club for Handbook of Viral Bioterrorism and Biodefense?

Sign up free on Readfeed, then browse public clubs or start your own club with Handbook of Viral Bioterrorism and Biodefense as the current read. Invite friends with a share link and discuss together with live chat and AI discussion questions.

Can I discuss Handbook of Viral Bioterrorism and Biodefense with other readers online?

Yes. Readfeed book clubs let you chat live, share progress, and join discussions about Handbook of Viral Bioterrorism and Biodefense with readers worldwide — whether your club is virtual, in-person, or hybrid.

Is Readfeed free?

Yes. Creating an account and joining book clubs is free. Sign up to find readers who love the same books and start discussing today.